DOCSLIB.ORG

Transmitimijeni Vector Kits Identified Vector???? Hits ?? ???? ???? ???? ?? ?? ?? ?????Identified ??? : : ??? ?? ? 900000 I

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Transmitimijeni Vector Kits Identified Vector???? Hits ?? ???? ???? ???? ?? ?? ?? ?????Identified ??? : : ??? ?? ? 900000 I US 20190255192A1 ( 19) United States (12 ) Patent Application Publication (10 ) Pub. No. : US 2019 /0255192 A1 KIRN et al. (43 ) Pub. Date : Aug . 22, 2019 ( 54 ) ADENO - ASSOCIATED VIRUS VARIANT CO7K 14 /005 ( 2006 .01 ) CAPSIDS AND METHODS OF USE THEREOF A61P 27/ 02 (2006 .01 ) (71 ) Applicant : 4D MOLECULAR THERAPEUTICS A61K 9 / 00 (2006 . 01) INC . , Emeryville, CA (US ) 2 ) U . S . CI. CPC . .. .. A61K 48 / 0016 ( 2013 .01 ) ; C12N 15 /86 (72 ) Inventors : David H . KIRN , Emeryville , CA (US ) ; (2013 .01 ) ; CO7K 14 / 005 ( 2013 .01 ) ; A61K Melissa KOTTERMAN , Emeryville , 48 / 0025 ( 2013 .01 ) ; A61K 9 /0048 (2013 . 01 ) ; CA (US ) ; David SCHAFFER , A61K 48 / 0075 ( 2013. 01 ) ; A61P 27 /02 Emeryville , CA (US ) ( 2018. 01 ) ; A61K 9 / 0019 ( 2013 .01 ) ; A61K (73 ) Assignee : 4D MOLECULAR THERAPEUTICS 48 / 0058 ( 2013 .01 ) INC . , Emeryville , CA ( US ) (21 ) Appl . No. : 16 /300 ,446 ( 57 ) ABSTRACT ( 22 ) PCT Filed : May 12 , 2017 Provided herein are variant adeno - associated virus (AAV ) ( 86 ) PCT No. : PCT/ US17 / 32542 capsid proteins having one or more modifications in amino $ 371 ( c )( 1 ) , acid sequence relative to a parental AAV capsid protein , ( 2 ) Date : Nov. 9 , 2018 which , when present in an AAV virion , confer increased infectivity of one or more types of retinal cells as compared Related U . S . Application Data to the infectivity of the retinal cells by an AA V virion (60 ) Provisional application No .62 /336 ,441 , filed on May comprising the unmodified parental capsid protein . Also 13 , 2016 , provisional application No . 62 /378 , 106 , provided are recombinant AAV virions and pharmaceutical filed on Aug. 22 , 2016 , provisional application No . compositions thereof comprising a variant AAV capsid pro 62 / 384, 590 , filed on Sep . 7 , 2016 , provisional appli tein as described herein , methods of making these rAAV cation No . 62/ 454 ,612 , filed on Feb . 3 , 2017 . capsid proteins and virions, and methods for using these TAAV capsid proteins and virions in research and in clinical Publication Classification practice, for example in , e . g . , the delivery of nucleic acid (51 ) Int . CI. sequences to one or more cells of the retina for the treatment A61K 48 / 00 ( 2006 .01 ) of retinal disorders and diseases . C12N 15 / 86 ( 2006 .01 ) Specification includes a Sequence Listing. SIRSWA 40MT Proprietary Libraries (n = 204) In Vivo Vector Selection : Vivo Vector Selection : resign . : od 200 muutos a @ob the 0 transmitimijeni Vector kits Identified Vector???? Hits ?? ???? ???? ???? ?? ?? ?? ?????Identified ??? : : ??? ?? ? 900000 i AAV. Capsid. .4VriA 2 Variants4 . PER Patent Application Publication Aug. 22 , 2019 Sheet 1 of 38 US 2019 /0255192 A1 a124444444447%. VivoVectorSelection: Stage2 extr IdentifiedHitsVector AAVCapsidVariants M24 wwwrrrr* 'r-47. v . IdentifiedVectorHits inVivoVectorSelection: Wehill .* th ? WWW Wh WWWWWWWWW!! M34 st * 2 KOO ** 0 !! !! i 4DMTProprietaryLibraries 0 . 200 BUIENRATIA WWW 0WW 1FIGURE . Patent Application Publication Aug. 22 , 2019 Sheet 2 of 38 US 2019 / 0255192 A1 :. arcadevascular ".: 1471 T513TI 12T4T6 fovea . B 6 15 S6S5 5453 S2S1 22 LeftEye 14 16 WT. ** ' NIN3N5 N6N4N2 N5N3N4N6 WIN 16 . 14 P #UZ WW Y : 15WWW :. VI B T6T412 Afovea FIGURE2 arcadevascular A Patent Application Publication Aug. 22 , 2019 Sheet 3 of 38 US 2019 / 0255192 A1 WHE WWW 2000x outmidoutinmidoutin Ult RPEONLINL RPEONLINLGCL midinout midinout WITH GCL outmidin WWW FIGURE3 Patent Application Publication Aug. 22 , 2019 Sheet 4 of 38 US 2019 / 0255192 A1 36.00 Round4 Round6 WWW. (6) (d) NE Round3 Round5 WE96VEL (a) © S FIGURE4 Patent Application Publication Aug. 22 , 2019 Sheet 5 of 38 US 2019 / 0255192 A1 WY FIGURE5 Patent Application Publication Aug. 22 , 2019 Sheet 6 of 38 US 2019 / 0255192 A1 ko 30 30 30 30 Sets PCAPKPK NOVY TER 20 1427 WWWWW WHERE POPKKAADGYIPD?LEDNESEGIREWWALKPGW W WWW. WRITE WEMO WALEXA BAADGYEPDWLEDTESEGTROWWKEKPOPÉPEK POPKPOWLEDNESEGIRENWALKPDRKAADEY?WWW RTDGYOPDÚBIEDNISECVREWWANOPGABERX EXTRARIAHLAX UNU . h RE 10 10 VANDRUPDWDSREGERENDUPOAPXPK WWW WERTHE 7777 Wh CA SHA WIR YUPO FAIXXVXOKOAX VAADGEPOISDNB SEN PUEDE UN . Hl BE WEET27 1 * " AAV3B(SEQIDNO:4) 2 AAVS(SEQIDNO:6) AAVG(SEOIDNO:7) AAVO(SEQIDNO:10) FIGURE6 Patent Application Publication Aug. 22 , 2019 Sheet 7 of 38 US 2019 / 0255192 A1 ? WWWS !? ? * 2 . 1 AVA VRH 17 THE71A/ 4* . 60 09 60 00 WWW ???????? VA . PENGEDKE MAXXX 2 2. os H 50 39 .WWW WA PROQHODOARCUVEPEYNYNGPENGEDRGEPIN EVAMA ANOOKODDERGLVOPGÝKYLGPPNGEDEGEPIN . 24. 92 PARKODSRPGYKIEGPFUGLDKGBP TARGET&PCYK BUL WALIO WAX ht ANOOKODE2 OONERS WWW 32 NEW ANQOKODDGRGIVLPGYKYILGPENGEDEGEPUN W ODBODRARGER 2007WALA LI NGORONGROPOLKUPENGER 2 22 MAS AAV2(SEQDNO:2) PAVBR(SEQIDNO:4) AAVA(SEQIDNO:5) AAVS(SEOIDNO:6) AAVO(SEQDNO:8) FIGURE6(contd) AAV10(SEQID Patent Application Publication Aug. 22 , 2019 Sheet 8 of 38 US 2019 / 0255192 A1 20 90 4 90 90 00 WWWWWWWWW WWW WWW 37277 ADABAZENDKAYDOKAGONPYURYNARDAR 4 BOKADOBRASONPADRYNRADAS AADBABLONDKAYDOOLLAGDARYERYNHADAS 30 AADAAAZSIDKAYDOOLKABRYNHADAGD 80 PADARDXBYDOORRAGDNPYEZINHADAS www SO EADÅAADERDKAYDROLDSGDNPYDKYNHADAN WHAT SADARANDKADOORKASDNPYZXYNRADAS wwwww 2 20 RADZARBADOSYNBOLAGDNPIERRADA70 70 ADBAARDRAIDODEKAGENPYRANHADAN70 W AAVBA(SEQIDNO:3) AAVI(SEQIDNO:1) AAV3B(SEQDNO:4) AAVS(SEQIDNO:6) AAV7(SEQIDNO:8) AAVS(SEQIDNO:9) AAVO(SEQIDNO:10) AAV10(SEQIDNO:11) 0233 Patent Application Publication Aug. 22 , 2019 Sheet 9 of 38 US 2019 / 0255192 A1 129 130 WW PPCD . WWW WWW 120 PAKKRESPEC120 120 120 120 re 010 601 WORKBOTSFOORBEEOAKKRUP FORREOBDTSEGREGRAZIOAKKREAPLES XX DOBROOTSIGOREGRAYSOARER MA 12. WORLOD32GBELGRZOAKKREDPLG LOORXOGOSPARAGRAFOAXKREEPEG OXBADDESIGN Harm FOLOSETSEGGKLGRASOAKER how Thomas sobooks 1)NO:IDSEQAAVI( AAV3B(SEQIDNO:4) AAV6(SEQIDNO:7) AAV7(SEQIDNO:8)23 AAVO(SEQIDNO:10) AAVIO(SEQIDNO:11) A FIGURE6(cont'd) (SEQ 1 Patent Application Publication Aug . 22 , 2019 Sheet 10 of 38 US 2019 /0255192 A1 091 159 159 139 159 160 160 *159 WA . WWW Who AXTAPIGXRIDDOPKRKLART-EDS w 149 350 150 190 150 . .. IA SA CACTEPERKRPSP-OPPSTICKYGY AKTABOXERPISOSPO-SDSSSGUGATOR WWW 77UDEPREZZO WRAAKTAPOKKRPSBOSPO-PDSSSCSKSGX 11 RAAKPAROKKCASOSPOLPDSSSGIORSOK GALAPARKROPSPORSPDSSTGGKUSO* ERAAKTAPGKKRETROSPO-EPDSSAGEGKSGA 140 A 129 140 140 . UK2 DRAAKTAPGKKRPEEPSPORSPDSSTGEGEKCO NA AAVBA(SEQIDNO:3) AAVIO(SEQIDNO:11) tir 2 AAV7(SEQIDNO:8) AAVE(SEQIDNO:9) AAVO(SEQIDNO:10) FIGURE6(cont'd) Ver YA ook Patent Application Publication Aug . 22 , 2019 Sheet 11 of 38 US 2019 /0255192 A1 mas Kok XXWh we Q.1 / FARIS WWW ost621 687 981 067 WY 061 .WWW L-ardaokaacausa909Paza I-dua2aoaga99899RONDO maWWW azadodiacansas?n WWW W SOPARKRINEGOTGDSESUPDPQPEGÖPPAAP- S-aydanozaaos20:09Nazao W 02 180 180 621 180 081 627 621 a ambalaagd$3991093128g ???????? wancein ???? ???? WWW WIRAWWW With relation was 169 post OLL 691 að At + V . 18 W12 AAVI(SEQIDNO:1) )NO:2IDSEQ(AAV2 AAVBA(SEQIDNO:3) 4):NOIDSEO(AAV3B 8):NOIDSEQ(AAV717 NO:9)SEQIDAAVE( WY Patent Application Publication Aug. 22 , 2019 Sheet 12 of 38 US 2019 /0255192 A1 72% YMAG 2.29 .Prs 228 228 228 222 218 228 229 228 229 W ASON . WS AHMINIMA WINWA UNION W VE 210 226 21.2 23% 219 612 218 219 WW EX WS SONRAGUNSSADPADASEGSITRASSGGA WWW WBXWA WWW SWEGADGAGNSSPADNESGSBELASGGGA 4 . * 22 * SGDIHGGBSRBIRADBGGAASGGOGADSDO GDWRGADGEGNASSAGGGGPGDNNODUSASAD SOMWAGADGGSSTRAAGGGAPRADACGSG 210 200 200 200 203 200 ay HEN27 Ken 22222 . 2 . 73 * an * wWS al R w ef. WS 29 HE 198 198 293 WWE 3.30 URUMEA 139 24 24 FIGURE6(cont'd) . AAV10(SEQIDNO:11) 1)NO:IDSEQAAVI( )NO:2IDSEQ(AAV2 4)NO:SEQ,IDAAV3B( AAVA(SEQIDNO:5) )NO6:IDSEQAAVS( AAVX(SEQIDNO:9) pour 3 Patent Application Publication Aug . 22 , 2019 Sheet 13 of 38 US 2019 /0255192 A1 WA 36 * NO 11 wa MW 259 258 252 W 240 259 259 258 1 EYROISSW USB C 00 4. WWXXXXX : 270 SSKOBRYTYNNPSTRTWALCDSTNEGDRETT 15 WWWW 249 248 242 ARNE 238 248 ZAKOISSPTYNNEDIAPRCOSTNEGORIOTTS NA NUPTINNEXOS3IRCORTASCoSon 22:13 23 ti UPLYNNYKORSSSTRINACOSINECORETT STRADOSNRE WA 239 240 gez 230 238 232 228STRTIPSYNCHOYBLIKSCOSTUMODRATX 236 WIB WWW * w UA2 ure 1 12 AU 3. AAVI(SEQIDNO:1) )NO:5IDSEQ(AAV4 )NO:8DSEO(AAV7 )NO:9DSEOAAVO( (SEQ Patent Application Publication Aug . 22 , 2019 Sheet 14 of 38 US 2019 /0255192 A1 3P WWW 11102 290 266 286 286 277 287 200 289 . BRFBCBPSP 280 276 276 276 267 277 279 SPPOPNROACHSZOSRTYNGESTPROY- YFGYSTISNANA YA mSDXBLOGY 02 GYFDFNRPRCRESPBESYSTPRSNDSTGA4- ho GYSTPAGYROPORRCROSPCASNODAYI- HOW 268 PWGYFDFNRFHCHFSPA-STGÅSNDNHYFGYST266 266 266 267 268 269 SNDNHYFGY?TPWGYFDFNRFHCHTSPSGA-0 VOX TNDNTYFCYSTPNGYFDFNRFECHPSPETSOGA SGGSTRDOTYPGYSTPRGYEDENRI 1 AAVI(SEQIDNO:1) NO2):IDSEQAAV2( )NO:3SEQIDAAVBA( )NO:6IDSEQAAVS( 8)NO:SEQIDAAV7(H ):9NOID(SEQAAV8 FIGURE6(cont'd) to *74 hoood 1 SLOW Patent Application Publication Aug . 22, 2019 Sheet 15 of 38 US 2019 /0255192 A1 329 330 326 3 WOMAN DOBRO 316 301 313 319 342 306 306 305 297 NDERZORROTTNGERPKRDROREN 308 BREAPRODITAPRPGRORORO309 302 GOPOR GUTONQERRDVORIINNNAGERPKKESFKEFNI):3NO KROSFKELÉERDVOEDIENNAGERP 292 296 28 287 267ZGPRERSERKOPALO2030 RONORED 297 298 NORORORDNINGERPEREREKBERO2)NO:IDSEQAAV2( SZKÖPROGRESSIONGEROKKUPOHOREN)NO:4IDSEQAAV3B( DROBNOZRPRESE at DORORDNINGERPRENORDENLOSEDN 11)NO:IDSEOAAV10( )NO:3IDSEQ(AAVBA NO5):SEODAAVA( 7)NO:IDSEQAAVO( 8)NO:IDSEQAAVO( NO9):IDSEQAAVE( 10)NO:IDSEQAAVO( S )'dcont(6FIGURE2 Patent Application Publication Aug . 22 , 2019 Sheet 16 of 38 US 2019 /0255192 A1 . A 323 358 358 359 356 . 22222222 GOEDÅYUHYELPFADSS YDLEGŠARO IAC 350 346 346 346 349 . WETDŠEYO?PYVEGŠAHO TVOVFTDŠEYOUPYVEGŠAHO. With ELGSASXPSDSSTEPODERATED WHA HOTÉTIANNÉTSTIONFTDŠEYONPYKTIGSAHQ w WA
Load more

Recommended publications
  • Organ Level Protein Networks As a Reference for the Host Effects of the Microbiome
    Downloaded from genome.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press 1 Organ level protein networks as a reference for the host effects of the microbiome 2 3 Robert H. Millsa,b,c,d, Jacob M. Wozniaka,b, Alison Vrbanacc, Anaamika Campeaua,b, Benoit 4 Chassainge,f,g,h, Andrew Gewirtze, Rob Knightc,d, and David J. Gonzaleza,b,d,# 5 6 a Department of Pharmacology, University of California, San Diego, California, USA 7 b Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, 8 California, USA 9 c Department of Pediatrics, and Department of Computer Science and Engineering, University of 10 California, San Diego California, USA 11 d Center for Microbiome Innovation, University of California, San Diego, California, USA 12 e Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State 13 University, Atlanta, GA, USA 14 f Neuroscience Institute, Georgia State University, Atlanta, GA, USA 15 g INSERM, U1016, Paris, France. 16 h Université de Paris, Paris, France. 17 18 Key words: Microbiota, Tandem Mass Tags, Organ Proteomics, Gnotobiotic Mice, Germ-free Mice, 19 Protein Networks, Proteomics 20 21 # Address Correspondence to: 22 David J. Gonzalez, PhD 23 Department of Pharmacology and Pharmacy 24 University of California, San Diego 25 La Jolla, CA 92093 26 E-mail: [email protected] 27 Phone: 858-822-1218 28 1 Downloaded from genome.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press 29 Abstract 30 Connections between the microbiome and health are rapidly emerging in a wide range of 31 diseases.
    [Show full text]
  • Miasdb: a Database of Molecular Interactions Associated with Alternative Splicing of Human Pre-Mrnas
    RESEARCH ARTICLE MiasDB: A Database of Molecular Interactions Associated with Alternative Splicing of Human Pre-mRNAs Yongqiang Xing1, Xiujuan Zhao1, Tao Yu2, Dong Liang1, Jun Li1, Guanyun Wei1, Guoqing Liu1, Xiangjun Cui1, Hongyu Zhao1, Lu Cai1* 1 School of Life Science and Technology, Inner Mongolia University of Science and Technology, Baotou, 014010, China, 2 School of Science, Inner Mongolia University of Science and Technology, Baotou, 014010, China a11111 * [email protected] Abstract Alternative splicing (AS) is pervasive in human multi-exon genes and is a major contributor to expansion of the transcriptome and proteome diversity. The accurate recognition of alter- OPEN ACCESS native splice sites is regulated by information contained in networks of protein-protein and Citation: Xing Y, Zhao X, Yu T, Liang D, Li J, Wei G, protein-RNA interactions. However, the mechanisms leading to splice site selection are not et al. (2016) MiasDB: A Database of Molecular fully understood. Although numerous databases have been built to describe AS, molecular Interactions Associated with Alternative Splicing of Human Pre-mRNAs. PLoS ONE 11(5): e0155443. interaction databases associated with AS have only recently emerged. In this study, we doi:10.1371/journal.pone.0155443 present a new database, MiasDB, that provides a description of molecular interactions Editor: Ruben Artero, University of Valencia, SPAIN associated with human AS events. This database covers 938 interactions between human splicing factors, RNA elements, transcription factors, kinases and modified histones for 173 Received: November 19, 2015 human AS events. Every entry includes the interaction partners, interaction type, experi- Accepted: April 28, 2016 mental methods, AS type, tissue specificity or disease-relevant information, a simple Published: May 11, 2016 description of the functionally tested interaction in the AS event and references.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT (51) International Patent Classification: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, C12Q 1/68 (2018.01) A61P 31/18 (2006.01) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, C12Q 1/70 (2006.01) HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (21) International Application Number: MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, PCT/US2018/056167 OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (22) International Filing Date: SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, 16 October 2018 (16. 10.2018) TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (26) Publication Language: English GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (30) Priority Data: UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 62/573,025 16 October 2017 (16. 10.2017) US TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, ΓΕ , IS, IT, LT, LU, LV, (71) Applicant: MASSACHUSETTS INSTITUTE OF MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TECHNOLOGY [US/US]; 77 Massachusetts Avenue, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, Cambridge, Massachusetts 02139 (US).
    [Show full text]
  • Supplementary Data Vigneswaran Et Al Supplementary Data
    Vigneswaran et al Supplementary Data Vigneswaran et al Supplementary Data Figure S1: Yki is required for EGFR-PI3K-driven glial neoplasia in Drosophila (A) Optical projections of whole brain-nerve cord complexes from 3rd instar larvae approximately 130 hrs old. Dorsal view; anterior up. CD8-GFP (green) labels glial cell bodies. Compared to repo>dEGFRλ;dp110CAAX, warts knockdown (repo>wartsdsRNA; dEGFRλ;dp110CAAX) increased neoplastic brain overgrowth and yki knockdown (repo>ykidsRNA;dEGFRλ;dp110CAAX) decreased neoplastic brain overgrowth. (B) 3 µm optical projections of brain hemispheres, age-matched 3rd instar larvae. Frontal sections; anterior up; midline to left. Repo (red) labels glial cell nuclei; CD8-GFP (green) labels glial cell bodies; anti-HRP (blue) counter-stains for neurons and neuropil. (middle) repo>dEGFRλ;dp110CAAX showed increased glial cell numbers (red nuclei) compared to (upper left) wild-type. Compared to repo>dEGFRλ;dp110CAAX, (right) warts knockdown increased neoplastic glial cell numbers (red nuclei), whereas (lower left) yki knockdown reduced neoplastic glial cell numbers (red nuclei). (C, D) Low levels of Yki protein (red) was observed in wild-type central brain glia (white arrows, left panel in C) compared to high levels of cytoplasmic and nuclear Yki protein in dEGFRλ;dp110CAAX neoplastic glia (white arrows, left panel in D); Repo (blue) labels glial cell nuclei; CD8-GFP (green) labels glial cell bodies. Vigneswaran et al Supplementary Data Figure S2: YAP/TAZ expression confined to RTK-amplified tuMor cells and Maintained in patient-derived xenografts (A) On the left, immunohistochemical (IHC) staining in representative normal brain parenchyma in the cortex where YAP expression and TAZ expression was limited to vascular cells and was not detectable in normal neuronal and glial cells.
    [Show full text]
  • Targeted Exome Capture and Sequencing Identifies Novel
    Open Access Research BMJ Open: first published as 10.1136/bmjopen-2013-004030 on 7 November 2013. Downloaded from Targeted exome capture and sequencing identifies novel PRPF31 mutations in autosomal dominant retinitis pigmentosa in Chinese families Liping Yang,1 Xiaobei Yin,2 Lemeng Wu,1 Ningning Chen,1 Huirong Zhang,1 Genlin Li,2 Zhizhong Ma1 To cite: Yang L, Yin X, Wu L, ABSTRACT et al Strengths and limitations of this study . Targeted exome capture Objectives: To identify disease-causing mutations in and sequencing identifies two Chinese families with autosomal dominant retinitis ▪ The HEDEP based on targeted exome capture novel PRPF31 mutations in pigmentosa (adRP). autosomal dominant retinitis technology is an efficient method for molecular pigmentosa in Chinese Design: Prospective analysis. diagnosis in adRP patients. families. BMJ Open 2013;3: Patients: Two Chinese adRP families underwent ▪ Both mutations result in premature termination e004030. doi:10.1136/ genetic diagnosis. A specific hereditary eye disease codons before the last exon, thus insufficient bmjopen-2013-004030 enrichment panel (HEDEP) based on targeted exome functioning due to haploinsufficiency instead of capture technology was used to collect the protein aberrant function of the mutated proteins seems ▸ Prepublication history and coding regions of targeted 371 hereditary eye disease to be the most probably reason in these two additional material for this genes; high throughput sequencing was done with the families. However no experiment was done to paper is available online. To Illumina HiSeq 2000 platform. The identified variants prove it in this study. view these files please visit were confirmed with Sanger sequencing. the journal online Setting: All experiments were performed in a large (http://dx.doi.org/10.1136/ laboratory specialising in genetic studies in the bmjopen-2013-004030).
    [Show full text]
  • Host Cell Factors Necessary for Influenza a Infection: Meta-Analysis of Genome Wide Studies
    Host Cell Factors Necessary for Influenza A Infection: Meta-Analysis of Genome Wide Studies Juliana S. Capitanio and Richard W. Wozniak Department of Cell Biology, Faculty of Medicine and Dentistry, University of Alberta Abstract: The Influenza A virus belongs to the Orthomyxoviridae family. Influenza virus infection occurs yearly in all countries of the world. It usually kills between 250,000 and 500,000 people and causes severe illness in millions more. Over the last century alone we have seen 3 global influenza pandemics. The great human and financial cost of this disease has made it the second most studied virus today, behind HIV. Recently, several genome-wide RNA interference studies have focused on identifying host molecules that participate in Influen- za infection. We used nine of these studies for this meta-analysis. Even though the overlap among genes identified in multiple screens was small, network analysis indicates that similar protein complexes and biological functions of the host were present. As a result, several host gene complexes important for the Influenza virus life cycle were identified. The biological function and the relevance of each identified protein complex in the Influenza virus life cycle is further detailed in this paper. Background and PA bound to the viral genome via nucleoprotein (NP). The viral core is enveloped by a lipid membrane derived from Influenza virus the host cell. The viral protein M1 underlies the membrane and anchors NEP/NS2. Hemagglutinin (HA), neuraminidase Viruses are the simplest life form on earth. They parasite host (NA), and M2 proteins are inserted into the envelope, facing organisms and subvert the host cellular machinery for differ- the viral exterior.
    [Show full text]
  • The Alter Retina: Alternative Splicing of Retinal Genes in Health and Disease
    International Journal of Molecular Sciences Review The Alter Retina: Alternative Splicing of Retinal Genes in Health and Disease Izarbe Aísa-Marín 1,2 , Rocío García-Arroyo 1,3 , Serena Mirra 1,2 and Gemma Marfany 1,2,3,* 1 Departament of Genetics, Microbiology and Statistics, Avda. Diagonal 643, Universitat de Barcelona, 08028 Barcelona, Spain; [email protected] (I.A.-M.); [email protected] (R.G.-A.); [email protected] (S.M.) 2 Centro de Investigación Biomédica en Red Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Universitat de Barcelona, 08028 Barcelona, Spain 3 Institute of Biomedicine (IBUB, IBUB-IRSJD), Universitat de Barcelona, 08028 Barcelona, Spain * Correspondence: [email protected] Abstract: Alternative splicing of mRNA is an essential mechanism to regulate and increase the diversity of the transcriptome and proteome. Alternative splicing frequently occurs in a tissue- or time-specific manner, contributing to differential gene expression between cell types during development. Neural tissues present extremely complex splicing programs and display the highest number of alternative splicing events. As an extension of the central nervous system, the retina constitutes an excellent system to illustrate the high diversity of neural transcripts. The retina expresses retinal specific splicing factors and produces a large number of alternative transcripts, including exclusive tissue-specific exons, which require an exquisite regulation. In fact, a current challenge in the genetic diagnosis of inherited retinal diseases stems from the lack of information regarding alternative splicing of retinal genes, as a considerable percentage of mutations alter splicing Citation: Aísa-Marín, I.; or the relative production of alternative transcripts. Modulation of alternative splicing in the retina García-Arroyo, R.; Mirra, S.; Marfany, is also instrumental in the design of novel therapeutic approaches for retinal dystrophies, since it G.
    [Show full text]
  • Mrna Editing, Processing and Quality Control in Caenorhabditis Elegans
    | WORMBOOK mRNA Editing, Processing and Quality Control in Caenorhabditis elegans Joshua A. Arribere,*,1 Hidehito Kuroyanagi,†,1 and Heather A. Hundley‡,1 *Department of MCD Biology, UC Santa Cruz, California 95064, †Laboratory of Gene Expression, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan, and ‡Medical Sciences Program, Indiana University School of Medicine-Bloomington, Indiana 47405 ABSTRACT While DNA serves as the blueprint of life, the distinct functions of each cell are determined by the dynamic expression of genes from the static genome. The amount and specific sequences of RNAs expressed in a given cell involves a number of regulated processes including RNA synthesis (transcription), processing, splicing, modification, polyadenylation, stability, translation, and degradation. As errors during mRNA production can create gene products that are deleterious to the organism, quality control mechanisms exist to survey and remove errors in mRNA expression and processing. Here, we will provide an overview of mRNA processing and quality control mechanisms that occur in Caenorhabditis elegans, with a focus on those that occur on protein-coding genes after transcription initiation. In addition, we will describe the genetic and technical approaches that have allowed studies in C. elegans to reveal important mechanistic insight into these processes. KEYWORDS Caenorhabditis elegans; splicing; RNA editing; RNA modification; polyadenylation; quality control; WormBook TABLE OF CONTENTS Abstract 531 RNA Editing and Modification 533 Adenosine-to-inosine RNA editing 533 The C. elegans A-to-I editing machinery 534 RNA editing in space and time 535 ADARs regulate the levels and fates of endogenous dsRNA 537 Are other modifications present in C.
    [Show full text]
  • Disrupted Alternative Splicing for Genes Implicated in Splicing and Ciliogenesis Causes PRPF31 Retinitis Pigmentosa
    ARTICLE DOI: 10.1038/s41467-018-06448-y OPEN Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa Adriana Buskin et al.# Mutations in pre-mRNA processing factors (PRPFs) cause autosomal-dominant retinitis pigmentosa (RP), but it is unclear why mutations in ubiquitously expressed genes cause non- 1234567890():,; syndromic retinal disease. Here, we generate transcriptome profiles from RP11 (PRPF31- mutated) patient-derived retinal organoids and retinal pigment epithelium (RPE), as well as Prpf31+/− mouse tissues, which revealed that disrupted alternative splicing occurred for specific splicing programmes. Mis-splicing of genes encoding pre-mRNA splicing proteins was limited to patient-specific retinal cells and Prpf31+/− mouse retinae and RPE. Mis-splicing of genes implicated in ciliogenesis and cellular adhesion was associated with severe RPE defects that include disrupted apical – basal polarity, reduced trans-epithelial resistance and phagocytic capacity, and decreased cilia length and incidence. Disrupted cilia morphology also occurred in patient-derived photoreceptors, associated with progressive degeneration and cellular stress. In situ gene editing of a pathogenic mutation rescued protein expression and key cellular phenotypes in RPE and photoreceptors, providing proof of concept for future therapeutic strategies. Correspondence and requests for materials should be addressed to S.-N.G. (email: [email protected]) or to C.A.J. (email: [email protected]) or to M.L. (email: [email protected]). #A full list of authors and their affliations appears at the end of the paper. NATURE COMMUNICATIONS | (2018) 9:4234 | DOI: 10.1038/s41467-018-06448-y | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06448-y etinitis pigmentosa (RP) is one of the most common c.522_527+10del heterozygous mutation (Supplementary Rinherited forms of retinal blindness with a prevalence of Data 1).
    [Show full text]
  • RBMX Family Proteins Connect the Fields of Nuclear RNA Processing
    International Journal of Biochemistry and Cell Biology 108 (2019) 1–6 Contents lists available at ScienceDirect International Journal of Biochemistry and Cell Biology journal homepage: www.elsevier.com/locate/biocel RBMX family proteins connect the fields of nuclear RNA processing, disease and sex chromosome biology T ⁎ David J. Elliott , Caroline Dalgliesh, Gerald Hysenaj, Ingrid Ehrmann Institute of Genetic Medicine, Newcastle University, Newcastle-upon-Tyne, NE1 3BZ, UK ARTICLE INFO ABSTRACT Keywords: RBMX is a ubiquitously expressed nuclear RNA binding protein that is encoded by a gene on the X chromosome. RNA splicing RBMX belongs to a small protein family with additional members encoded by paralogs on the mammalian Y Gene expression chromosome and other chromosomes. These RNA binding proteins are important for normal development, and Brain development also implicated in cancer and viral infection. At the molecular level RBMX family proteins contribute to splicing Testis control, transcription and genome integrity. Establishing what endogenous genes and pathways are controlled by Cancer RBMX and its paralogs will have important implications for understanding chromosome biology, DNA repair and mammalian development. Here we review what is known about this family of RNA binding proteins, and identify important current questions about their functions. 1. Introduction et al., 1993). While RBMX is expressed ubiquitously through the body, RBMY genes are specifically expressed in germ cells (cells that even- RBMX (an acronym of RNA Binding Motif protein, X-linked) was tually develop into sperm). Multiple RBMY genes are present on the originally identified as one of a functionally diverse group of nuclear long arm of the human Y chromosome, each encoding 496 amino acid proteins that bind to polyadenylated RNA.
    [Show full text]
  • Supplemental Table 2
    Supplemental Table 2 probeID geneSymbol geneTitle cox.tt 223518_at DFFA DNA fragmentation factor, 45kDa, alpha polypeptide 4.86807974 212370_x_at FAM21A /// FAM21B /// FAM21C family with sequence similarity 21, member A /// family with sequence similarity 21, member B /// family with sequence similarity 21, member C -4.039911936 228937_at C13orf31 chromosome 13 open reading frame 31 -3.965652752 224217_s_at FAF1 Fas (TNFRSF6) associated factor 1 3.818692986 219066_at PPCDC phosphopantothenoylcysteine decarboxylase 3.812463041 200994_at IPO7 importin 7 3.722967297 203853_s_at GAB2 GRB2-associated binding protein 2 -3.576924648 218118_s_at TIMM23 translocase of inner mitochondrial membrane 23 homolog (yeast) -3.525051556 238662_at ATPBD4 ATP binding domain 4 3.522716621 212905_at CSTF2T cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa, tau variant -3.458703211 225075_at PDRG1 p53 and DNA-damage regulated 1 3.437886045 211430_s_at IGH@ /// IGHG1 /// IGHG2 /// IGHM /// IGHV4-31 /// LOC100294459 immunoglobulin heavy locus /// immunoglobulin heavy constant gamma 1 (G1m marker) /// immunoglobulin heavy constant gamma 2 (G2m marker) /// immunoglobulin heavy constant mu /// immunoglobulin heavy variable 4-31 /// similar to immunoglobulin lambda-like polypeptide 1 -3.404297079 244181_at 244181_at --- -3.363118329 202231_at EIF3M eukaryotic translation initiation factor 3, subunit M 3.345657723 201160_s_at CSDA cold shock domain protein A 3.337512802 214946_x_at FAM21A /// FAM21B /// FAM21C /// FAM21D family with sequence similarity 21,
    [Show full text]